Omega Healthcare Investors, Inc. (OHI) Expected to Announce Quarterly Sales of $226.89 Million

Equities analysts predict that Omega Healthcare Investors, Inc. (NYSE:OHI) will report $226.89 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Omega Healthcare Investors’ earnings. The highest sales estimate is $237.38 million and the lowest is $207.75 million. Omega Healthcare Investors reported sales of $224.64 million during the same quarter last year, which would suggest a positive year over year growth rate of 1%. The business is expected to announce its next quarterly earnings results on Monday, October 30th.

On average, analysts expect that Omega Healthcare Investors will report full year sales of $226.89 million for the current year, with estimates ranging from $906.28 million to $947.15 million. For the next fiscal year, analysts forecast that the business will report sales of $966.87 million per share, with estimates ranging from $925.30 million to $1.01 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow Omega Healthcare Investors.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Wednesday, July 26th. The real estate investment trust reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.16). Omega Healthcare Investors had a net margin of 40.20% and a return on equity of 8.88%. The business had revenue of $194.00 million for the quarter, compared to the consensus estimate of $194.59 million. During the same period in the prior year, the company earned $0.87 EPS. Omega Healthcare Investors’s quarterly revenue was up 4.0% on a year-over-year basis.

A number of equities analysts have recently commented on the stock. Jefferies Group LLC reaffirmed a “hold” rating and set a $30.00 price objective on shares of Omega Healthcare Investors in a report on Tuesday, October 3rd. ValuEngine raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Thursday, September 28th. Finally, BidaskClub downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $32.63.

Omega Healthcare Investors (NYSE:OHI) opened at 31.28 on Tuesday. Omega Healthcare Investors has a 52-week low of $28.11 and a 52-week high of $35.14. The company has a market cap of $6.17 billion, a PE ratio of 16.51 and a beta of 0.53. The firm has a 50-day moving average of $31.90 and a 200 day moving average of $32.53.

TRADEMARK VIOLATION WARNING: This report was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://ledgergazette.com/2017/10/10/omega-healthcare-investors-inc-ohi-expected-to-announce-quarterly-sales-of-226-89-million.html.

A number of hedge funds have recently made changes to their positions in OHI. UBS Asset Management Americas Inc. lifted its holdings in Omega Healthcare Investors by 20.7% during the 1st quarter. UBS Asset Management Americas Inc. now owns 367,420 shares of the real estate investment trust’s stock valued at $12,121,000 after purchasing an additional 62,968 shares during the last quarter. Parametric Portfolio Associates LLC lifted its holdings in Omega Healthcare Investors by 3.6% during the 1st quarter. Parametric Portfolio Associates LLC now owns 186,324 shares of the real estate investment trust’s stock valued at $6,147,000 after purchasing an additional 6,493 shares during the last quarter. OppenheimerFunds Inc. lifted its holdings in Omega Healthcare Investors by 24.1% during the 1st quarter. OppenheimerFunds Inc. now owns 40,626 shares of the real estate investment trust’s stock valued at $1,340,000 after purchasing an additional 7,889 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Omega Healthcare Investors by 482.5% during the 1st quarter. Wellington Management Group LLP now owns 162,343 shares of the real estate investment trust’s stock valued at $5,355,000 after purchasing an additional 134,472 shares during the last quarter. Finally, FMR LLC lifted its holdings in Omega Healthcare Investors by 26.7% during the 1st quarter. FMR LLC now owns 1,366,518 shares of the real estate investment trust’s stock valued at $45,082,000 after purchasing an additional 287,612 shares during the last quarter. 72.84% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Get a free copy of the Zacks research report on

On average, analysts expect that Omega Healthcare Investors will report full year sales of $226.89 million for the current year, with estimates ranging from $906.28 million to $947.15 million. For the next fiscal year, analysts forecast that the business will report sales of $966.87 million per share, with estimates ranging from $925.30 million to $1.01 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow Omega Healthcare Investors.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Wednesday, July 26th. The real estate investment trust reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.16). Omega Healthcare Investors had a net margin of 40.20% and a return on equity of 8.88%. The business had revenue of $194.00 million for the quarter, compared to the consensus estimate of $194.59 million. During the same period in the prior year, the company earned $0.87 EPS. Omega Healthcare Investors’s quarterly revenue was up 4.0% on a year-over-year basis.

A number of equities analysts have recently commented on the stock. Jefferies Group LLC reaffirmed a “hold” rating and set a $30.00 price objective on shares of Omega Healthcare Investors in a report on Tuesday, October 3rd. ValuEngine raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Thursday, September 28th. Finally, BidaskClub downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $32.63.

Omega Healthcare Investors (NYSE:OHI) opened at 31.28 on Tuesday. Omega Healthcare Investors has a 52-week low of $28.11 and a 52-week high of $35.14. The company has a market cap of $6.17 billion, a PE ratio of 16.51 and a beta of 0.53. The firm has a 50-day moving average of $31.90 and a 200 day moving average of $32.53.

TRADEMARK VIOLATION WARNING: This report was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://ledgergazette.com/2017/10/10/omega-healthcare-investors-inc-ohi-expected-to-announce-quarterly-sales-of-226-89-million.html.

A number of hedge funds have recently made changes to their positions in OHI. UBS Asset Management Americas Inc. lifted its holdings in Omega Healthcare Investors by 20.7% during the 1st quarter. UBS Asset Management Americas Inc. now owns 367,420 shares of the real estate investment trust’s stock valued at $12,121,000 after purchasing an additional 62,968 shares during the last quarter. Parametric Portfolio Associates LLC lifted its holdings in Omega Healthcare Investors by 3.6% during the 1st quarter. Parametric Portfolio Associates LLC now owns 186,324 shares of the real estate investment trust’s stock valued at $6,147,000 after purchasing an additional 6,493 shares during the last quarter. OppenheimerFunds Inc. lifted its holdings in Omega Healthcare Investors by 24.1% during the 1st quarter. OppenheimerFunds Inc. now owns 40,626 shares of the real estate investment trust’s stock valued at $1,340,000 after purchasing an additional 7,889 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Omega Healthcare Investors by 482.5% during the 1st quarter. Wellington Management Group LLP now owns 162,343 shares of the real estate investment trust’s stock valued at $5,355,000 after purchasing an additional 134,472 shares during the last quarter. Finally, FMR LLC lifted its holdings in Omega Healthcare Investors by 26.7% during the 1st quarter. FMR LLC now owns 1,366,518 shares of the real estate investment trust’s stock valued at $45,082,000 after purchasing an additional 287,612 shares during the last quarter. 72.84% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply